Tech Company Financing Transactions
Novel Biotechnology Funding Round
Ontario Centres of Excellence and private investors participated in a $2.5 million Seed funding round for Novel Biotechnology. The round was announced on 9/28/2023.
Transaction Overview
Company Name
Announced On
9/28/2023
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand its existing plasmid services business and expedite its platform R&D
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
81 Zenway Blvd, Unit 3A
Vaughan, Ontario, L4H 0S5
CA
Vaughan, Ontario, L4H 0S5
CA
Phone
Website
Email Address
Overview
Novel Biotechnology is a Synthetic Biology company focused on developing highly productive pDNA manufacturing platform. We also provide CRDMO and plasmid DNA manufacturing services to our clients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pankaj Khanna
Chief Technical Officer
Matthew Weinstock
Co-Founder
Todd Morgan
Co-Founder
Konstantin Rodionov
Browse more venture capital transactions:
Prev: 9/28/2023: Overfuel venture capital transaction
Next: 9/28/2023: The Grand World venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs